Register for Upcoming Webinar on DEC. 8 @ 11AM

2024 China NMPA Bluebook is here:

Maccura and Qiagen Formed a Joint Venture in China


China’s Maccura Biotechnology formed a joint venture with Qiagen of the Netherlands to develop and market Qiagen’s GeneReader NGS system in China. Maccura is a China IVD company. It will own 60% of the JV, which is named Maqgen, while Qiagen will own the rest. Qiagen claims the GeneReader NGS System is the world’s first complete Sample-to-Insight reader and makes NGS available to any laboratory. The JV will focus initially on research use of the machine and broaden that to include Class III hospital networks.

China Med Device, LLC, specializing in providing turn-key solutions for medtech companies entry into China, with services in capital injection, funding partnership, joint venture, merger & acquisition consulting. If you have any feedback on this post or would like to know more of our services, please email us at or visit us at

Have Questions?

Related Services


Recent Events

Related Posts


Get Updated

Receive Updates in Your Inbox